missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Adenosine-2',3'-cyclic monophosphate sodium salt, 97%, Thermo Scientific Chemicals
Click to view available options
Quantity:
100 mg
250 mg
500 mg
Description
Adenosine-2’,3’-cyclic Monophosphate is an Adenosine (A280400) derivative useful as anticancer agent. It is also used as a Pharmaceutical intermediate, pharmaceutical research and chemical analysis.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Adenosine-2’,3’-cyclic Monophosphate is an Adenosine (A280400) derivative useful as anticancer agent. It is also used as a Pharmaceutical intermediate, pharmaceutical research and chemical analysis.
Solubility
It is soluble in DMSO, water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Hygroscopic. Keep away fom strong oxidizing agents.
Adenosine-2’,3’-cyclic Monophosphate is an Adenosine (A280400) derivative useful as anticancer agent. It is also used as a Pharmaceutical intermediate, pharmaceutical research and chemical analysis.
Solubility
It is soluble in DMSO, water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Hygroscopic. Keep away fom strong oxidizing agents.
Specifications
Specifications
Melting Point | 241°C to 243°C |
Color | White |
Quantity | 250 mg |
Solubility Information | It is soluble in DMSO,water. |
Formula Weight | 351.19 |
Percent Purity | 97% |
Physical Form | Powder |
Chemical Name or Material | Adenosine-2',3'-cyclic monophosphate sodium salt |
RUO – Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction